Vanda Pharmaceuticals
Vanda Pharmaceuticals Inc is an American commercial-stage biopharmaceutical enterprise headquartered in Washington, DC. The company specializes in the research, development, and commercialization of innovative specialty pharmaceutical products targeting central nervous system disorders and rare diseases, including treatments for sleep-wake disorders and psychiatric conditions. Principal revenue is derived through commercial pharmaceutical product sales of approved prescription medications (such as Hetlioz and Fanapt) to healthcare markets. Vanda Pharmaceuticals is publicly listed on the Nasdaq Stock Market.
3 of the funds FundTelligence covers report a position in Vanda Pharmaceuticals.
- Legal name
- VANDA PHARMACEUTICALS INC
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 3
- Exposure themes
- Mental Health, Psychiatry, Schizophrenia & Psychosis
Funds holding Vanda Pharmaceuticals
- KLP AksjeGlobal Small Cap Flerfaktor — KLP · 0.23 % (full portfolio disclosed, June 2026)
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.02 % (full portfolio disclosed, October 2026)
- BlackRock iShares NASDAQ US Biotechnology UCITS ETF — BlackRock · 0.02 % (full portfolio disclosed, October 2026)